Company / Operating Income per Share
Rani Therapeutics Holdings, Inc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1872.24
FY2025
5-year range
-$2641.50 / -$0.85
FY2021-FY2025
Trend
+27.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2641.50 to $-1872.24 over the past 3 years.
Based on SEC 10-K filings.
-1872.24 in FY2025.
Improved from $-2641.50 to $-1872.24 over the past 3 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 27.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1872.24 | +27.8% |
| FY2024 | -$2591.61 | +1.9% |
| FY2022 | -$2641.50 | -311789.5% |
| FY2021 | -$0.85 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026